Nucleome Therapeutics Limited
Nucleome Therapeutics Limited is an active company incorporated on 17 July 2019 with the registered office located in Oxford, Oxfordshire. Nucleome Therapeutics Limited was registered 6 years ago.
Status
Active
Active since incorporation
Company No
12109297
Private limited company
Age
6 years
Incorporated 17 July 2019
Size
Unreported
Confirmation
Submitted
Dated 16 August 2025 (2 months ago)
Next confirmation dated 16 August 2026
Due by 30 August 2026 (10 months remaining)
Last change occurred 2 months ago
Accounts
Submitted
For period 1 Aug ⟶ 31 Dec 2024 (5 months)
Accounts type is Small
Next accounts for period 31 December 2025
Due by 30 September 2026 (11 months remaining)
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Dr Jonathan Paul Hepple is a mutual person.
Active
Dr Jonathan Paul Hepple is a mutual person.
Active
Dr Jonathan Paul Hepple is a mutual person.
Active
Dr Jonathan Paul Hepple is a mutual person.
Active
Emma Johnson is a mutual person.
Active
Emma Johnson is a mutual person.
Active
Dr Bauke Anninga is a mutual person.
Active
Brands
Nucleome Therapeutics is a biotechnology company focused on decoding the regulatory genome to develop precision medicines.
Financials
Net Assets, Total Assets & Total Liabilities (2020–2024)
Period Ended
31 Dec 2024
For period 31 Jul ⟶ 31 Dec 2024
Traded for 5 months
Cash in Bank
£12.29M
Decreased by £7.57M (-38%)
Turnover
£156K
Increased by £131K (+524%)
Employees
44
Increased by 10 (+29%)
Total Assets
£24.34M
Decreased by £3.29M (-12%)
Total Liabilities
-£1.31M
Increased by £481K (+58%)
Net Assets
£23.03M
Decreased by £3.77M (-14%)
Debt Ratio (%)
5%
Increased by 2.38% (+79%)
Get Credit Report
Discover Nucleome Therapeutics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
